Loading data
CBTNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 3.71 bn USD | 3.99 bn USD | 3.93 bn USD | 4.32 bn USD |
| Cost of revenue | 2.77 bn USD | 3.03 bn USD | 3.09 bn USD | 3.44 bn USD |
| Gross profit | 940 m USD | 960 m USD | 839 m USD | 885 m USD |
| Research and development expense | 59 m USD | 63 m USD | 57 m USD | 55 m USD |
| Selling, general and administrative expense | 260 m USD | 283 m USD | 253 m USD | 258 m USD |
| Operating profit | 621 m USD | 614 m USD | 526 m USD | 389 m USD |
| Interest expense | 76 m USD | 81 m USD | 90 m USD | 56 m USD |
| Income tax expense | 196 m USD | 111 m USD | -28 m USD | 102 m USD |
| Net income (reported basis) | 331 m USD | 380 m USD | 445 m USD | 209 m USD |
| Net income attributable to common shareholders | 326 m USD | 374 m USD | 437 m USD | 206 m USD |
| Basic earnings per share | 6.07 USD/share | 6.79 USD/share | 7.79 USD/share | 3.65 USD/share |
| Diluted earnings per share | 6.02 USD/share | 6.72 USD/share | 7.73 USD/share | 3.62 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.